Author:
Du Yu,Peyser Noah D.,Grandis Jennifer R.
Subject
Pharmacology (medical),Pharmacology
Reference81 articles.
1. Nimotuzumab: evidence of clinical benefit without rash;Allan;Oncologist,2005
2. A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III–IV head and neck squamous cell carcinomas (HNC);Ang,2011
3. Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: a GICOR phase I trial;Arias de la Vega;Ann Oncol,2012
4. Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck;Bastholt;Radiother Oncol,2007
5. Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa);Bianco;Clin Cancer Res,2002
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献